Research map: Achieving Hepatitis C Micro-Elimination in a High-Burden Province of Thailand: The Phetchabun Model

Back to the article

Papers in this map

  1. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡ · Richard K. Sterling · 2006 · 5001 citations · Cited by this paper
  2. High Positivity Rate for Leptospira Infection in Symptomatic Urban Owned Dogs in Guayaquil, Ecuador · 2026 · Related
  3. EASL recommendations on treatment of hepatitis C: Final update of the series☆ · Jean–Michel Pawlotsky · 2020 · 1269 citations · Cited by this paper
  4. Optimising Post-Delivery Viral Load Monitoring and HIV Care to Eliminate Breastfeeding-Associated HIV Transmission in Sub-Saharan Africa: A Review · 2026 · Related
  5. Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD Fibrosis · Stuart McPherson · 2016 · 945 citations · Cited by this paper
  6. Rickettsia parkeri as a Probable Agent of Mild Spotted-Fever Group Rickettsiosis Identified by Seroreactivity in Villeta, Colombia · 2026 · Related
  7. Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection · Graham R. Foster · 2015 · 860 citations · Cited by this paper
  8. Perinatal HIV in Europe: Clinical Advances and Psychosocial Challenges—A Scoping Review · 2026 · Related
  9. The Micro-Elimination Approach to Eliminating Hepatitis C: Strategic and Operational Considerations · Kelly Safreed‐Harmon · 2018 · 267 citations · Cited by this paper
  10. Molecular Identification of Schistosoma Species Associated with Atypical Urinary Eggs in Abuja (Nigeria): Evidence of Potential Zoonotic Transmission · 2026 · Related
  11. Micro-elimination – A path to global elimination of hepatitis C · Jeffrey Victor Lazarus · 2017 · 238 citations · Cited by this paper
  12. Global, Regional, and National Burden of Malaria and Dengue from 1992 to 2021, with Projections to 2036: An Age–Period–Cohort Analysis · 2026 · Related
  13. Launch of a Nationwide Hepatitis C Elimination Program — Georgia, April 2015 · Kiren Mitruka · 2015 · 113 citations · Cited by this paper
  14. Submicroscopic Plasmodium falciparum Carriage and Molecular Markers of Antimalarial Drug Resistance Among Outpatients Attending Korle Bu Teaching Hospital, Ghana · 2026 · Related
  15. Global real‐world evidence of sofosbuvir/velpatasvir as simple, effective HCV treatment: Analysis of 5552 patients from 12 cohorts · Alessandra Mangia · 2020 · 108 citations · Cited by this paper
  16. Enhancing Infectious Disease Preparedness in Rome: The Lazio Regional Network During the 2025 Jubilee · 2026 · Related
  17. The Success of a Universal Hepatitis B Immunization Program as Part of Thailand’s EPI after 22 Years’ Implementation · Nawarat Posuwan · 2016 · 106 citations · Cited by this paper
  18. Cutaneous Leishmaniasis in Tigray, North Ethiopia: Community Awareness, Perceptions, Treatment-Seeking, and Prevention Practices in Disease Endemic Areas · 2026 · Related
  19. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study · Behzad Hajarizadeh · 2021 · 102 citations · Cited by this paper
  20. Non-Neonatal Tetanus in Mogadishu, Somalia: Clinical Characteristics, Management, and Outcomes—First Report from a Tetanus Referral Centre · 2026 · Related
  21. Uptake of direct‐acting antiviral treatment for chronic hepatitis C in Australia · Behzad Hajarizadeh · 2017 · 93 citations · Cited by this paper
  22. Treatment of chronic hepatitis C virus infection in Rwanda with ledipasvir–sofosbuvir (SHARED): a single-arm trial · Neil Gupta · 2018 · 88 citations · Cited by this paper
  23. Treatment as Prevention for Hepatitis C (TraP Hep C) – a nationwide elimination programme in Iceland using direct‐acting antiviral agents · Sigurdur Oli Olafsson · 2018 · 85 citations · Cited by this paper
  24. HCV micro-elimination in individuals with HIV in the Netherlands 4 years after universal access to direct-acting antivirals: a retrospective cohort study · Colette Smit · 2020 · 74 citations · Cited by this paper
  25. The Role of Screening and Treatment in National Progress Toward Hepatitis C Elimination — Georgia, 2015–2016 · Muazzam Nasrullah · 2017 · 63 citations · Cited by this paper
  26. Rwanda launches a 5-year national hepatitis C elimination plan: A landmark in sub-Saharan Africa · Grace Umutesi · 2019 · 60 citations · Cited by this paper
  27. Three Years of Progress Toward Achieving Hepatitis C Elimination in the Country of Georgia, April 2015–March 2018 · Tengiz Tsertsvadze · 2019 · 45 citations · Cited by this paper
  28. Elimination of Hepatitis C Virus in a Dialysis Population: A Collaborative Care Model in Taiwan · Tsung‐Hui Hu · 2021 · 42 citations · Cited by this paper
  29. Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region · Pojsakorn Danpanichkul · 2024 · 40 citations · Cited by this paper
  30. Hepatitis C Elimination in Egypt: Story of Success · Asmaa Ibrahim Gomaa · 2024 · 38 citations · Cited by this paper
  31. Cascade of care during the first 36 months of the treatment as prevention for hepatitis C (TraP HepC) programme in Iceland: a population-based study · Sigurdur Oli Olafsson · 2021 · 37 citations · Cited by this paper
  32. Controlling hepatitis C in Rwanda: a framework for a national response · Aimable Mbituyumuremyi · 2017 · 36 citations · Cited by this paper
  33. Reduced incidence of hepatitis C in 9 villages in rural Egypt: Progress towards national elimination goals · Gamal El-Sayed Shiha · 2020 · 31 citations · Cited by this paper
  34. Assessment of hepatitis C virus infection in two adjacent Thai provinces with drastically different seroprevalence · Rujipat Wasitthankasem · 2017 · 30 citations · Cited by this paper
  35. Hepatitis C prevalence and elimination planning in Pakistan, a bottom‐up approach accounting for provincial variation · Ellen Mooneyhan · 2023 · 29 citations · Cited by this paper
  36. Sofosbuvir/Velpatasvir for Hepatitis C Virus Infection: Real-World Effectiveness and Safety from a Nationwide Registry in Taiwan · Pin‐Nan Cheng · 2021 · 28 citations · Cited by this paper
  37. Lessons Learned From Global Hepatitis C Elimination Programs · Senad Handanagić · 2023 · 27 citations · Cited by this paper
  38. Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a population-based study · Rujipat Wasitthankasem · 2018 · 26 citations · Cited by this paper
  39. Prevalence of Hepatitis C Virus in an Endemic Area of Thailand: Burden Assessment toward HCV Elimination · Rujipat Wasitthankasem · 2020 · 26 citations · Cited by this paper

Source: OpenAlex (CC0)